JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Zafgen Announces Pricing of Offering of Common Stock
-
Neuronetics, Inc. (STIM) Prices 5.5M Share IPO at $17/Sh
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering
-
EverQuote, Inc. (EVER) Prices 4.69M Share IPO at $18/Sh
-
JMP Securities Downgrades Summit Therapeutics plc (SMMT) to Market Perform
-
JMP Securities Starts BRT Apartments (BRT) at Market Outperform
-
ERYTECH Pharma SA. (ERYP) PT Lowered to $33 at JMP Securities
-
EverQuote Announces Pricing of Initial Public Offering
-
Zillow (Z) Announces $325M Class C Capital Shares Offering; Also Announces Proposed $325M Convertible Senior Note Offering
-
Zillow Group Announces Proposed Public Offerings of $325 million of Class C Capital Stock and $325 million of Convertible Senior Notes
-
Zillow Group Announces Proposed Public Offerings of $325 million of Class C Capital Stock and $325 million of Convertible Senior Notes
-
Zafgen (ZFGN) Plans Offering of Common Stock
-
Zafgen Announces Proposed Offering of Common Stock
-
Zafgen Announces Proposed Offering of Common Stock
-
ServiceSource International (SREV) PT Raised to $5.50 at JMP Securities
-
Veritone, Inc. Announces Closing of Public Offering of Common Stock
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
Cybereason's CEO Lior Div is a 2018 EY 'Entrepreneur of the Year' Finalist
-
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Kiniksa Pharmaceuticals, Ltd. Announces Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Sarepta Therapeutics (SRPT) Updated PT Settles At 'Street High' $275 - JMP
-
Enova International (ENVA) PT Raised to $42 at JMP Securities
-
electroCore (ECOR) IPO Opens 20% Higher
-
Green Brick Partners (GRBK) Confirms 7.1M Share Pricing at $9.50
-
Green Brick Partners, Inc. Announces Pricing of Common Stock Offering
-
Green Brick Partners, Inc. Announces Pricing of Common Stock Offering
-
electroCore, Inc. (ECOR) Prices 5.2M Share IPO at $15/Sh
-
TPI Composites (TPIC) PT Raised to $36 at JMP Securities
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
Industrial Logistics Properties Trust to Participate at Two Industry Conferences
-
Veritone, Inc. (VERI) Prices 1.7M Share Common Stock Offering at $18/Sh
-
Veritone, Inc. Prices Public Offering of Common Stock
-
Veritone, Inc. (VERI) Announces Proposed Common Share Offering
-
Veritone, Inc. Announces Proposed Public Offering of Common Stock
-
Deciphera Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st
-
ERYTECH to Present at JMP Securities Life Science Conference
-
ERYTECH to Present at JMP Securities Life Science Conference
-
Avalara Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Avenue Therapeutics to Participate in JMP Securities Life Sciences Conference
-
Avenue Therapeutics to Participate in JMP Securities Life Sciences Conference
-
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
-
Catalyst Biosciences to Present at the JMP Securities 2018 Life Sciences Conference
-
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
-
Dermavant to Present at JMP Securities Life Science Conference
-
Deciphera (DCPH) PT Raised to $65 at JMP Securities; 'Based On Our Risk-Adjusted NPV Model'
-
JMP Group Announces Addition of Carin Fradin to Investment Banking Division

